Farther Finance Advisors LLC Has $1.52 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Farther Finance Advisors LLC reduced its holdings in shares of The Clorox Company (NYSE:CLX) by 3.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,342 shares of the company’s stock after selling 372 shares during the period. Farther Finance Advisors LLC’s holdings in Clorox were worth $1,522,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. SG Americas Securities LLC grew its stake in shares of Clorox by 1,525.7% in the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after purchasing an additional 61,576 shares during the period. Mizuho Markets Americas LLC raised its stake in Clorox by 93.7% during the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after acquiring an additional 34,864 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its holdings in shares of Clorox by 15.2% during the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after acquiring an additional 18,687 shares during the period. Advisors Asset Management Inc. boosted its stake in shares of Clorox by 257.5% in the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after purchasing an additional 8,087 shares in the last quarter. Finally, Raymond James & Associates grew its holdings in shares of Clorox by 32.8% in the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company’s stock worth $36,524,000 after purchasing an additional 66,149 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.57% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on CLX. DA Davidson reaffirmed a “neutral” rating and set a $153.00 price objective on shares of Clorox in a research note on Friday, September 6th. Barclays raised their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday. Deutsche Bank Aktiengesellschaft boosted their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, TD Cowen began coverage on shares of Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $150.29.

Clorox Stock Performance

CLX stock opened at $163.11 on Monday. The Clorox Company has a twelve month low of $121.76 and a twelve month high of $169.09. The company has a quick ratio of 0.63, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market cap of $20.19 billion, a P/E ratio of 56.83, a price-to-earnings-growth ratio of 3.09 and a beta of 0.41. The business’s fifty day moving average is $161.48 and its 200-day moving average is $146.19.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue was up 27.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.49 earnings per share. Equities research analysts forecast that The Clorox Company will post 6.79 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 2.99%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.